Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...
The recalled "Connie's Thin Crust Cheese Pizza" was issued a Class II risk level by the FDA, the second-most severe risk ...
Opponents argue that the change could cause current smokers to use more cigarettes to compensate for the lower nicotine ...
The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...
The FDA has set maximum levels for lead in baby food. A new California law requires baby food makers selling products in the ...
Years of research have showed that pulse oximeters yield less accurate readings for people with darker skin tones, and now ...
By Sneha S K and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration said on Friday that it has approved an ...
Following the FDA’s release of a guidance requesting more diversity in pulse oximeter testing, the number of clearance ...
The U.S. food supply is generally considered safe, but tens of millions of people get sick from foodborne illnesses each year ...
The FDA's draft recommendations for pulse oximeters aims to include clinical studies involving at least 150 participants with ...